We welcome you to the next 2022 PDA BioManufacturing Conference!
This year, the Scientific Program Planning Committee and the PDA have joined forces with the Lyophilization Conference to offer a full experience including emerging trends on biomanufacturing and regulatory focus areas. We will come together as a 3 – track conference face-to-face in Amsterdam / The Netherlands on 20-21 September 2022.
Over the last years, we have seen a tremendous acceleration in all aspects of biopharmaceutical development, due to the health emergency, which revealed many opportunities for exploring new technologies, development approaches and regulatory frameworks to support rapid access of vaccines and biotherapeutics as well as sustainable life cycle management. The conference will provide the opportunity to discuss all these aspects: the theme of this edition will be Biopharmaceutical Solutions to Prepare for Healthcare Challenges.
The 2022 Biomanufacturing conference will emphasize topics including product, process and analytical development, aseptic manufacturing, supply chain challenges, lifecycle strategies, new technologies, environmental sustainability, regulatory approaches.
You will have the opportunity to expand your network, interacting with professionals from Industry, Academia, Research Institutes and Health Agencies.
We look forward to seeing you in September!
Cristiana Campa, GSK Vaccines
Raf De Dier, Janssen
SCIENTIFIC PROGRAM PLANNING COMMITTEE
- Cristiana Campa, GSK Vaccines (Chair)
- Raf De Dier, Janssen (Chair)
- Marta Antunes, MSD
- Thomas Beutler, GEA Lyophil
- Michael De Felippis, Eli Lilly and Company
- Thierry Gastineau, Sanofi
- Sabine Hauck, Leukocare
- Susanne Joerg, ten23 health
- Julian Lenger, Bayer
- Yves Mayeresse, GSK
- Arnaud Paris, BioMerieux
- Elisabeth Vachette, Sartorius
- Josh Eaton, PDA
- Falk Klar, PDA
- Sabine Hartmann, Manager Programs & Events, PDA